It’s been a busy week for Optimum, with some amazing original content from our clients, with this week’s podcast highlighting their expertise in cutting-edge lung cancer research. In our weekly hot topic article, they give predictions for the 2025 outlook following November’s London Life Sciences Week. We also have five clients nominated for the prestigious […]
By Richard Staines London Life Sciences Week has become a major fixture on the biotech calendar with two conferences – the LSX Inve$tival and the Jefferies London Healthcare Conference – plus the LSX Lifestars Awards all falling within one working week. This year’s Jefferies event expanded from its traditional home at the Waldorf Astoria Hotel […]
Optimum Client’s Win Big at LSX European Lifestars Awards! Congratulations to Optimum’s clients – Asceneuron SA, Calliditas Therapeutics, DISCO Pharmaceuticals GmbH, Sofinnova Partners portfolio company Moon Surgical, Myricx Bio, and Novo Holdings, all of whom took home LSX European Lifestars awards! Plus, a special moment for Optimum’s Zoe Bolt who presented the award for Private […]
Just days after anti-vaxxer Robert F Kennedy Jr was nominated as President-elect Donald Trump’s health secretary, the first case of the mpox strain of most concern to scientists has been recorded in the U.S. While mpox has been declared a global health emergency by the World Health Organization, U.S. public health officials have not seemed […]
During the BIO-Europe conference in Stockholm, Optimum co-hosted a special reception featuring a fireside chat with Renée Aguiar-Lucander, former CEO of Calliditas, who led the Swedish company since 2017 until recently – taking it from small biotech to its $1.1 billion acquisition. Here, we tell the story of her remarkable seven-year journey with the firm. Novo […]
